SNMMI: FDG-PET/MRI improves pain diagnosis, management
June 24, 2019 -- ANAHEIM, CA - By identifying increased metabolic activity or inflammation associated with chronic pain, FDG-PET/MRI can improve care management strategies for a majority of patients, according to a study presented Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Read More
SNMMI: PSMA-PET helps guide prostate cancer therapy
June 23, 2019 -- ANAHEIM, CA - Adding an interim prostate-specific membrane antigen (PSMA)-PET scan during therapy can help guide treatment for patients with prostate cancer, according to a study presented Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Read More
Immuno-PET could aid patients with inflammatory diseases
June 20, 2019 -- PET imaging with radiotracers to accurately identify molecules in cancer cells that prevent the immune system from attacking a disease, called immuno-PET, could become an effective tool in assessing inflammatory bowel disease, according to a preclinical study published in the June issue of the Journal of Nuclear Medicine. Read More
New class of radiotracers targets many cancer types
June 12, 2019 -- Oncologists and nuclear medicine technologists may soon have another weapon in their arsenal to diagnose and evaluate various cancers through PET/CT, according to a study published in the June issue of the Journal of Nuclear Medicine. Read More
Most diabetes patients unprepared for FDG-PET/CT scans
June 10, 2019 -- Many nuclear medicine practices are neglecting to tell patients with diabetes that their medications could affect the image quality of their FDG-PET/CT scans, according to a study published in the June issue of the Journal of the American College of Radiology. Read More
NaF-PET/CT rarely finds prostate cancer bone metastases
June 3, 2019 -- Sodium fluoride (NaF) PET/CT rarely adds value for detecting bone metastases in patients with intermediate- and high-risk prostate cancer and normal bone scintigraphy results prior to prostatectomy, according to a study published online May 30 in the Journal of Nuclear Medicine. Read More
IMV: PET/CT drives PET scan volume to new heights
May 20, 2019 -- Procedure volume in the PET market hit the highest level ever in the U.S., with adoption of PET/CT scanners mainly responsible for driving growth. More than 2 million PET scans were performed in the U.S. in 2018, according to a new market research report by IMV Medical Information Division. Read More
Radiation events prompt FDA notice on Rb-82 generators
May 1, 2019 -- The U.S. Food and Drug Administration (FDA) has bolstered its requirement for safety labels on rubidium-82 (Rb-82) generators for PET studies. The action follows reports of a "serious incident" of excess radiation exposure to patients caused by what the FDA called "user error." Read More
NIH awards grant to develop PET plaque tracers
May 1, 2019 -- The U.S. National Institutes of Health (NIH) has awarded a $5.1 million grant to researchers at Mallinckrodt Institute of Radiology to develop PET-based imaging tools to distinguish vulnerable plaque in the body. Read More
Would high amyloid level spur physician-assisted death?
April 30, 2019 -- If physician-assisted death were legal, how many people with elevated beta-amyloid levels would opt for it if they experienced a cognitive decline due to Alzheimer's disease? Not that many, according to a research letter published online April 29 in JAMA Neurology. Read More